1. 20‐year follow‐up of Hodgkin lymphoma: Predictors of survival and secondary malignancies. (June 2017) Authors: Vallansot, R.O.; Talarn, C.; Cervera, M.; Do Nascimento, J.; Gumà, J.; Miranda, M.J.; Martínez, F.; Herranz, M.J.; Prats, M.; Ortín, X.; Aguinaco, R.; Gimenez, M.T.; Araguás, C.; Esteban, A.; Martínez, A.; Sarra, J.; Escoda, L. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 90 INTENSIVE CHEMOTHERAPY VERSUS NO INTENSIVE TREATMENT IN HIGH RISK MYELODYSPLASTYC SYNDROME (MDS) NO-HSCT CANDIDATES. (April 2015) Authors: Bargay, J.; Xicoy, B.; Brunet, S.; Tormo, M.; Pedro, C.; Coll, R.; Talarn, C.; Marti, J.M.; Nomdedeu, M.; Font, X.; Sampol, A.; Borrás, J.; Valcárcel, D.; Ribera, J.M.; Sierra, J. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to Azacitidine in a Series of 94 Patients with Chronic Myelomonocytic Leukemia from the Spanish Group of Myelodysplastic Syndromes. (April 2017) Authors: Triguero, A.; Xicoy, B.; Jiménez, M.J.; García, O.; Ramos, F.; Calabuig, M.; Liang, T.H.C.; Arzuaga, J.; Díaz-Beyá, M.; Medina, Á.; Bernal, T.; Brunet, S.; Coll, R.; Collado, R.; Borrás, J.; Talarn, C.; Sanz, G. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria. (May 2022) Authors: Triguero, A.; Xicoy, B.; Zamora, L.; Jiménez, MJ.; García, O.; Calabuig, M.; Díaz-Beyá, M.; Arzuaga, J.; Ramos, F.; Medina, A.; Bernal, T.; Talarn, C.; Coll, R.; Collado, R.; Chen, T.Hua; Borrás, J.; Brunet, S.; Marchante, I.; Marco, V.; López-Cadenas, F. Journal: Leukemia research Issue: Volume 116(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF GERIATRIC ASSESSMENT AND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016–1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP. (May 2023) Authors: Amer, N.; Cabezón, M.; Xicoy, B.; Garrido, A.; Baena, N.; Canet, M.; Arnan, M.; Arenillas, L.; Coll, R.; Ortin, X.; Diaz, M.; Talarn, C.; García-Caro, M.; Zamora, L.; Bargay, J. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗